ERMA — Enorama Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK88.39m
- SEK86.29m
- SEK2.74m
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO
Brief: Enorama Pharma Sells Nicotine Gum Business Assets To Aflofarm
Brief: Enorama Pharma Q1 Operating Loss Narrows To SEK 10.9 Mln
Brief: Enorama Pharma Reports Q4 Net Sales Of SEK 1.75 Million
Brief: Balance Sheet For Liquidation Purposes Shows Enorama Pharma Equity Is Less Than Half Of Registered Share Capital
Brief: Enorama Pharma Postpones Publication Of 2025 Report Due To Control Balance Sheet
Brief: Enorama Pharma Enters Loan Agreement With DS Global
Brief: Enorama Pharma Postpones Its 2025 Year-End Report
Brief: Enorama Pharma To Prepare Balance Sheet For Liquidation Purposes
Brief: Enorama Pharma Subsidiary Intends To Appeal FDA's Refuse-To-File Decision
Brief: Enorama Pharma Q3 Operating Loss Widens To SEK 12.3 Mln
Brief: Enorama Pharma CEO Daniel Schröder Resigns
Brief: Enorama Pharma Q2 Net Sales SEK 733,000
Brief: Enorama Pharma To Raise About SEK 15.6 Mln Through Directed Share Issue
Brief: Enorama Pharma Appoints Jonas Brisland As CFO
Brief: Enorama Pharma Q1 Net Sales Up At 449 Ksek